Article By:
ChinaBio® Today
Saturday, August 19, 2017 2:57 PM EDT
Harbin Gloria Pharma and WuXi Biologics have entered an ex-China agreement for a PD-1 antibody with Arcus Biosciences of California's Bay Area in a deal worth up to $818 million.